3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex

Detailed studies of the properties of 3H-3-N-methylspiperone (NMSP) binding in rat and human brain homogenates were performed at 37 degrees C. In homogenates of rat striatum and frontal cortex and human caudate and frontal cortex tissues, the specific binding was found to be saturable. Rat caudate contained 33.2 pmol/gm wet-weight tissue and displayed an equilibrium dissociation constant (Kd) of 8.7 X 10(-11) M; rat frontal cortex contained 18.5 pmol/gm wet-weight tissue and displayed a Kd of 1.5 X 10(-10) M. Human caudate contained 8.96 pmol/gm wet-weight tissue and displayed a Kd of 1.1 X 10(-10) M; human frontal cortex possessed 9.8 pmol/gm wet-weight tissue and a Kd of 4.4 X 10(- 10) M. Kinetic studies revealed a very rapid rate of association in all the tissues studied. The rate of dissociation was relatively slow in all 4 tissue preparations; the dissociation rate was somewhat slower in rat striatum and human caudate relative to rat and human frontal cortex. This was consistent with the somewhat higher affinity, relative to frontal cortex, displayed by 3H-NMSP in rat striatal and human caudate tissue. The pharmacological properties of the specific binding in rat striatal and human caudate tissues were very similar and indicated the presence of brain D2 dopamine receptors. In rat and human frontal cortex tissue homogenates, the pharmacological characteristics of the specific binding indicated the presence of 5-HT2 receptors.

[1]  W. Burkard,et al.  Benzodiazepine Antagonist Ro 15–1788: Binding Characteristics and Interaction with Drug‐Induced Changes in Dopamine Turnover and Cerebellar cGMP Levels , 1982, Journal of neurochemistry.

[2]  S. Snyder,et al.  MULTIPLE DOPAMINE RECEPTORS , 1979 .

[3]  S. Snyder,et al.  [3H]nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Greengrass,et al.  Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors. , 1979, European journal of pharmacology.

[5]  M. Titeler,et al.  Guanyl Nucleotide and Divalent Cation Regulation of Cortical S2 Serotonin Receptors , 1984, Journal of neurochemistry.

[6]  S. Snyder,et al.  [3H]Para-amino-clonidine: A novel ligand which binds with high affinity to α-adrenergic receptors , 1979 .

[7]  C. Braestrup,et al.  Benzodiazepine receptors in rat brain , 1977, Nature.

[8]  S. Freedman,et al.  Binding of [3H]sulpiride to purified rat striatal synaptic membranes , 1981, Neuroscience.

[9]  J. Hyttel.  Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro. , 1981, Life sciences.

[10]  S. Snyder,et al.  [3H]Para-amino-clonidine: a novel ligand which binds with high affinity to alpha-adrenergic receptors. , 1979, Life sciences.

[11]  P Riederer,et al.  Bimodal distribution of dopamine receptor densities in brains of schizophrenics. , 1984, Science.

[12]  J. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography. , 1984, Science.

[13]  D. Sibley,et al.  The classification of dopamine receptors: relationship to radioligand binding. , 1983, Annual review of neuroscience.

[14]  P J Whitehouse,et al.  Effects of Postmortem Delay and Temperature on Neurotransmitter Receptor Binding in a Rat Model of the Human Autopsy Process , 1984, Journal of neurochemistry.

[15]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[16]  J M Links,et al.  Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  S. Snyder,et al.  Species variation in dopamine receptor binding. , 1979, European journal of pharmacology.

[18]  Jonathan M. Links,et al.  Imaging dopamine receptors in the human brain by positron tomography , 1983 .

[19]  N. Birdsall,et al.  Pirenzepine distinguishes between different subclasses of muscarinic receptors , 1980, Nature.

[20]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[21]  P. Seeman,et al.  Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Herbet,et al.  Serotonin-sensitive adenylate cyclase and [3]serotonin binding sites in the CNS of the rat—I: Kinetic parameters and pharmacological properties , 1980 .

[23]  J. Maloteaux,et al.  Characterization and regional distribution of serotonin S2-receptors in human brain , 1983, Brain Research.

[24]  M. Folstein,et al.  EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.

[25]  S. Snyder,et al.  [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. , 1984, Molecular pharmacology.

[26]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 3. Subcellular distribution of neuroleptic drugs and their receptors in various rat brain areas. , 1978, Biochemical pharmacology.

[27]  M. Martres,et al.  Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. , 1985, Science.

[28]  B. Perry,et al.  [3H]rauwolscine (α-yohimbine): A specific antagonist radioligand for brain α2-adrenergic receptors , 1981 .

[29]  A. Herbet,et al.  Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I. , 1980, Biochemical pharmacology.

[30]  A. Gjedde,et al.  Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.